바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2010, v.69 no.2, pp.108-114


  • Downloaded
  • Viewed

Abstract

Background: The aim was to estimate the differences between pulmonary disability grades according to the spirometry reference equations (the Korean equation and the Morris equation). Methods: Spirometry was performed on 16,916 male and 1,353 female special examination for pneumoconiosis, in the period of 2007∼2009. Changes in predictive values for forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and FEV1/FVC and in disability grade were evaluated using both equations. Results: Mean FVCs for men and women were 4,218.7 mL and 2,801.5 mL in predictive values after the application of the Korean equation, and 3,763.9 mL and 2,395.6 mL after the Morris equation, respectively. Compared with the Morris equation, the Korean equation showed 10.8% and 14.5% of excesses for men and women (p<0.001). Mean FEV1s for men and women were 3,102.5 mL and 2,107.1 mL in the Korean equation, and 2,667.8 mL and 1,699.6 mL in the Morris equation, respectively. Compared with the Morris equation, the Korean equation showed 14.0% and 19.3% of excesses for men and women (p<0.001). Men and women who showed the changes of disability grades using the Korean equation in place of the Morris equation were 23.9% (4,052/16,916) and 22.9% (311/1,353) on FVC, and 23.1% (3,913/16,916) and 10.7% (145/1,353) on FEV1. Conclusion: Applying different reference equations for spirometry has resulted in changes for disability grades in special examination for pneumoconiosis.

keywords
Spirometry, Pneumoconiosis, Morris Equation, Korean Equation, Spirometry, Pneumoconiosis, Morris Equation, Korean Equation

Reference

1.

1. Paek D, Choi JK, Choi BS, Chung KC. Normal predictive values of FVC and FEV1 for healthy Korean male workers. Korean J Occup Environ Med 1994;6:175-86.

2.

2. Miller MR, Hankinson J, Brusasco V, Burgos F,Casaburi R, Coates A, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26: 319-38.

3.

3. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005;26:153-61.

4.

4. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies.Am Rev Respir Dis 1991;144:1202-18.

5.

5. American Thoracic Society. Standardization of spirometry:1994 update. Am J Respir Crit Care Med 1995;152:1107-36.

6.

6. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis 2005;58:230-42.

7.

7. Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971;103:57-67.

8.

8. Kory RC, Callahan R, Boren HG, Syner JC. The Veterans Administration-Army cooperative study of pulmonary function. I. Clinical spirometry in normal men.Am J Med 1961;30:243-58.

9.

9. Oh YM, Hong SB, Shim TS, Lim CM, Koh Y, Kim WS,et al. Effect of a new spirometric reference equation on the interpretation of spirometric patterns and disease severity. Tuberc Respir Dis 2006;60:215-20.

Tuberculosis & Respiratory Diseases